WellSpan-THRIVE Cancer QOL Study
Recruiting now
Conditions studied: Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative, Cancer (Solid Tumors), Cancer (With or Without Metastasis), Cancer - Ovarian, Cancer Abdomen, Cancer (Advanced Stage)
In brief
Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.
Key facts
- Study ID
- NCT07433660
- Run by
- WellSpan Health
- People needed
- 1000
- Starts
- 2026-02-01
- Expected to finish
- 2031-12-01
- Last updated by the study team
- 2026-03-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 years and above
- Primary cancer diagnosis (newly diagnosed within the past 6 months)
- Able to sign informed consent.
You may not qualify if…
- Patients with age<18 years,
- Patients with primary non-melanoma skin, neurological malignancies (Brain or brain metastases), and primary hematological malignancies.
- Patients with severe cognitive impairment, unable to sign informed consent or unable to complete quality of life questionnaire.
- Patients with life expectancy of <90 days, in the opinion of treating investigator.
Where it is running
- WellSpan Medical Oncology & Hematology — Chambersburg, Pennsylvania, United States (enrolling)
- WellSpan Ephrata Cancer Center — Ephrata, Pennsylvania, United States (enrolling)
- WellSpan Adams Cancer Center — Gettysburg, Pennsylvania, United States (enrolling)
- WellSpan Sechler Family Cancer Center — Lebanon, Pennsylvania, United States (enrolling)
- WellSpan York Cancer Center — York, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.